The application of comprehensive genomic methodology has successfully identified the presence of frequently mutated genes, including CREBBP (15–17%), Rbl2, MYC, EP300, FRFR1, and PLCG2, in tumors of patients diagnosed with SCLC. The gene discussed is MYC; the disease is small cell lung carcinoma.